Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: I don’t have a reliable, up‑to‑the‑minute list of telehealth services that still supply compounded GLP‑1 products — and for safety/regulatory reasons most reputable telehealth companies stopped offering compounded GLP‑1s after the FDA warnings. If you’re looking for GLP‑1 treatment, it’s safer to work with a telehealth provider that prescribes FDA‑approved GLP‑1 medicines (Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound) rather than seeking compounded versions.

Services to consider (they prescribe FDA‑approved GLP‑1s and use licensed prescribers)

• PlushCare — national telehealth primary‑care/urgent‑care provider that evaluates and prescribes weight‑loss or diabetes medications when appropriate. Good for ongoing follow up.
• Hims & Hers — has offered GLP‑1 programs through licensed clinicians and is set up as a direct telehealth/retail model.
• Ro (including their weight‑loss/Zero services) — provides telehealth evaluation and prescriptions for FDA‑approved weight‑loss meds.
• GoodRx Care / NowRx telehealth partners — can connect you to clinicians who may prescribe FDA‑approved GLP‑1s and provide pharmacy options.
• Local health‑system telehealth (e.g., One Medical, large hospital systems’ telemedicine clinics) — often safer because they integrate with your medical records.

Why these are better than compounded GLP‑1s

• They prescribe FDA‑approved, clinically tested products with known quality, dosing, and safety profiles.
• Licensed clinicians provide evaluation and follow‑up.
• Less risk of contamination, incorrect potency, or adulterated products.

If you still want a telehealth+compounding route (be cautious)

• Ask the telehealth service to name the compounding pharmacy and verify:
  • State pharmacy license and whether it’s a 503A (patient‑specific) or 503B (outsourcing) facility.
  • PCAB accreditation or other quality accreditations.
  • USP <795>/<797> or <800> compliance for sterile compounding if injectable.
  • Whether they provide a Certificate of Analysis (COA) or independent lab testing for each batch.
  • Where the product is shipped from and which prescriber signed the prescription.
• Check state pharmacy board and NABP records for the pharmacy and the prescriber.

Why I’m cautious

• The FDA has warned many compounded GLP‑1 products are adulterated or misbranded and may pose safety risks. Some compounding pharmacies were subject to enforcement. Buying compounded injectable GLP‑1s that are not made under strict sterile and quality controls can be dangerous.

If your goal is affordability or access during shortage:

• Ask clinicians about manufacturer coupons, patient‑assistance programs, lower‑cost formulations (e.g., oral Rybelsus where appropriate), or authorized pharmacy alternatives.
• Discuss clinical suitability of an FDA‑approved option with a clinician rather than using an unverified compounded product.

If you want, tell me:

• your state (laws and availability vary), and whether you want a telehealth visit that leads to an FDA‑approved prescription or you specifically want information on compounding pharmacies — I can then give more targeted guidance on how to verify a provider safely.